One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes did not meet its primary endpoint, but a preplanned subgroup analysis found a statistically significant effect of treatment ...
Apr 8, 2024
0
18
Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.
Mar 8, 2024
0
10
For scalp psoriasis, 0.1 percent tacrolimus microemulsion has good efficacy and safety, according to a study published online Feb. 12 in Dermatology and Therapy.
Mar 6, 2024
0
0
For patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARĪ“) agonist seladelpar have a biochemical response and alkaline phosphatase normalization, according ...
Feb 27, 2024
0
0
Melatonin treatment does not affect the insulin resistance or the glucose tolerance of night shift workers, according to a new study from the University of Surrey and the University Medical Centre Hamburg. Melatonin treatment ...
Feb 19, 2024
0
0
For patients with acute ischemic stroke secondary to large-vessel occlusion (LVO) undergoing endovascular thrombectomy, adjuvant low-dose methylprednisolone does not improve the degree of overall disability, according to ...
Feb 14, 2024
0
0
For patients with moderate-to-severe plaque psoriasis, the interleukin-23-receptor antagonist peptide JNJ-77242113 shows greater efficacy than placebo, according to a study published in the Feb. 8 issue of the New England ...
Feb 8, 2024
0
0
A study from the University of Oklahoma College of Medicine at OU Health Sciences shows that stimulating the body's longest nerve through a clip on the ear significantly lessens the woozy symptoms of POTS, or postural tachycardia ...
Feb 5, 2024
0
54
A new study at the University of Missouri's Thompson Center for Autism and Neurodevelopment has found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for kids and young adults with ...
Jan 23, 2024
0
1
For adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in the Jan. 18 issue of the New England ...
Jan 18, 2024
0
0
